Richard Colbeck (Tasmania, Liberal Party, Minister for Senior Australians and Aged Care Services) Share this | Hansard source

The Therapeutic Goods Administration has recently recognised two additional COVID-19 vaccines for the purpose of establishing a traveller's vaccination status. This includes Covaxin, manufactured by Bharat Biotech, India, and BBIBP-CorV, manufactured by Sinopharm, in China. Covaxin is recognised for travellers aged 12 and over, and BBIBP-CorV is recognised for those aged 18 to 60. This means that many citizens of China and India, as well as other countries where vaccines have been widely used, will be considered fully vaccinated on entry to Australia. This is especially important as we welcome international students back to our shores. There are now eight COVID-19 vaccines that have been approved or recognised by the TGA for entry into Australia, and work continues to acknowledge more.